News
Akero Therapeutics' efruxifermin shows strong potential in MASH, especially compensated cirrhosis. Click here to find out why ...
GSK will incorporate the findings into messaging that depemokimab patients will adhere to treatment better, ensuring better ...
Sexual health services in the UK will start rolling out a 'world-first' vaccine programme designed to protect people from gonorrhoea in August.
Depemokimab reduces exacerbations regardless of baseline asthma control, suggesting uncontrolled symptoms are not necessary ...
Endurance Techn, Solar Ind, GlaxoSmithKline, Gland, and Motilal Oswal marked their presence among the top gainers in the ...
Nifty Pharma stocks, including GSK, Jubilant Pharmova, Eris Life, Gland Pharma and Torrent Pharma, saw gains up to 8% as ...
“This is a high-quality study that stands out mainly for its sample size. The results confirm previous findings that people with a history of cold sores have a higher risk of developing Alzheimer’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results